Company attributes
Industry
B2X
CEO
Number of Employees (Ranges)
11 – 50
Full Address
55 Cambridge Pkwy, Ste 800E, Cambridge, Massachusetts, 02142, United States
Total Funding Amount (USD)
167,000,000
Latest Funding Round Date
July 28, 2021
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
117,000,000
Ring Therapeutics is a multi-product platform company that focuses on finding and developing Anellovector therapeutics, to unbar the potential of gene therapy. Ring Therapeutics harnesses the biology of the human commensal virome.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
